Radica Alicic

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Bayer
    Topic:
    CKD
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Boehringer Ingelheim
    Topic:
    CKM , CKD
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Boehringer Ingelheim
    Topic:
    study PI
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Otsuka
    Topic:
    IgA nephropathy
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Novo Nordisk
    Topic:
    CKD , CVD
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    Novartis
    Topic:
    CKD
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    ProKidney
    Topic:
    CKD
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    AstraZeneca,
    Topic:
    CKD
    Date added:
    09/12/2026
    Date updated:
    09/12/2026
Return to Washington ACC 2026 Annual Meeting